You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《盈警響號》雍禾醫療(02279.HK)料去年淨虧損不高於5.5億元人幣
阿思達克 03-11 08:57
雍禾醫療(02279.HK)預期截至去年12月底止年度,錄得收入約17.65億至17.8億元人民幣(下同),按年增長約24.9%至26%;年度淨虧損不高於5.5億元,而2022年度虧損為8,590萬元。 公司指,虧損擴大主要由於順應中國消費醫療服務市場環境及毛髮醫療服務行業發展的變化,戰略性優化組織架構,人工成本相應增加;為提升營銷渠道效率,進行了拓展線上獲客途徑的階段性探索,使年度銷售費用較2022年全年有所增加,增幅約36%至37%; 為適應市場變化,並基於對中國髮發醫療服務市場前景看好,戰略性調整市場佈局,於該年度新開業21家雍禾植髮醫療機構和7家史雲遜健髮中心,相應的成本支出有所增加;同時,為提升院部整體盈利能力,進行區域性資源整合,收縮部分低線城市門店,錄得一次性虧損約5,360萬元。 公司指,當前經濟環境充滿挑戰與不確定性,但通過科學的戰略規劃和有效的營運管理,公司有能力應對這些挑戰。2024年將進一步優化人工成本,嚴控銷售費用率,提高營運效率,相信有關措施將對2024年的業務發展帶來促進作用。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account